跳至主要内容
临床试验/NCT02848196
NCT02848196Unknown不适用

A Phase II Trial of Image-guided Stereotactic Body Radiation Therapy (SBRT) for Adrenal Gland Metastasis in Oligometastatic Patients

Istituto Clinico Humanitas2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2016年10月19日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
40
试验地点
2
主要终点
Control of local disease

研究概览

简要总结

The study is designed to to assess the efficacy of ablative SBRT delivered with VMAT technique in oligometastatic patients affected by adrenal gland metastases.

详细描述

This is a phase II, single arm, trial for testing efficacy of ablative high hypofractionated dose delivered with VMAT technique in oligometastatic patients with adrenal gland metastases. The potential advantages of this approach include the possibility to lead an increased local control in irradiated adrenal gland metastases. Other purpose of this study is to assess acute and late toxicity in terms of maintenance of endocrine mechanisms of hormonal production.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18years.
  • WHO performance status ≤ 1 (ECOG - KPS).
  • Histologically-proven of primary cancer disease
  • Metastases at adrenal gland radiologically proven
  • Written informed consent

排除标准

  • Prior radiation to the interested adrenal gland.
  • Patients allergic to contrast used in CT scans or who cannot be premedicated for the use of contrast.

结局指标

主要结局

Control of local disease

时间窗: 5 years

Evaluation of proportion of patients free from progression from starting radiotherapy according to CTCAE v4.03

次要结局

  • Incidence of acute and late complications(5 years)
  • Endocrine mechanisms of hormonal production(5 years)

研究者

发起方
Istituto Clinico Humanitas
申办方类型
Other
责任方
Principal Investigator
主要研究者

Michele Tedeschi

MD

Istituto Clinico Humanitas

研究点 (2)

Loading locations...

相似试验